MANILA (Reuters) - The Philippines' Food and Drug Administration has authorised for emergency use the COVID-19 vaccine developed by Pfizer and BioNTech, the first to be approved in the country, which has among the most coronavirus cases in Asia.
FDA head Rolando Enrique Domingo said the Pfizer-BioNTech vaccine, which has shown a 95% success rate, could be effective in preventing COVID-19, with which nearly half a million people in the Philippines have been infected.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!